InMode confirmed that it has received an unsolicited proposal from MN Business Strategy and said it will evaluate the offer.
In its offer, MN Business Strategy would acquire all outstanding shares of the medical technology company that it doesn't already own for $16.20 apiece.
InMode said Wednesday that its board has formed a special committee of independent directors to evaluate the proposal.
The company noted that it can't assure whether the evaluation will result in a deal, and that it doesn't intend to provide further comment on the process until required to do so by law or regulation.
InMode's shares climbed 11%, to $14.83, in premarket trading.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
June 24, 2026 09:04 ET (13:04 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments